# ZNF438

## Overview
ZNF438 is a gene that encodes the zinc finger protein 438, a member of the zinc finger protein family characterized by the presence of zinc finger domains. These domains are crucial for the protein's ability to bind to DNA, RNA, or other proteins, thereby influencing gene expression and cellular processes. Zinc finger protein 438 is involved in various cellular functions, potentially regulated by post-translational modifications such as phosphorylation and ubiquitination, which can affect its stability and interactions. The protein may exist in multiple isoforms due to alternative splicing, allowing it to participate in diverse biological roles. ZNF438 has been associated with several diseases, including osteosarcoma, bronchopulmonary dysplasia, and prostate cancer, highlighting its significance in both normal physiology and pathological conditions (Jaratlerdsiri2017Next; Sun2022Comprehensive; Cuna2015Alterations).

## Clinical Significance
ZNF438 has been implicated in several diseases due to alterations in its expression levels and genetic mutations. In osteosarcoma, a type of bone cancer, lower expression of ZNF438 is associated with worse overall survival, suggesting it may act as a protective factor. This gene is part of a prognostic signature that correlates with immune-related pathways, indicating that patients with lower ZNF438 expression might experience an immune suppressive state and potentially have a poor response to immune checkpoint inhibitors (Sun2022Comprehensive).

In the context of bronchopulmonary dysplasia (BPD), a lung condition, ZNF438 shows decreased methylation and increased expression, which suggests a potential role in the pathophysiology of BPD. This alteration in expression is significant, with a reported 10-fold increase in BPD lungs compared to preterm lungs (Cuna2015Alterations).

In prostate cancer, a somatic deletion within the ZNF438 gene has been identified, although the specific implications of this deletion on disease progression or patient outcomes are not detailed (Jaratlerdsiri2017Next). These findings highlight the diverse roles of ZNF438 in different diseases, emphasizing the need for further research to fully understand its clinical significance.


## References


[1. (Jaratlerdsiri2017Next) Weerachai Jaratlerdsiri, Eva K.F. Chan, Desiree C. Petersen, Claire Yang, Peter I. Croucher, M.S. Riana Bornman, Palak Sheth, and Vanessa M. Hayes. Next generation mapping reveals novel large genomic rearrangements in prostate cancer. Oncotarget, 8(14):23588–23602, March 2017. URL: http://dx.doi.org/10.18632/oncotarget.15802, doi:10.18632/oncotarget.15802. This article has 40 citations and is from a poor quality or predatory journal.](https://doi.org/10.18632/oncotarget.15802)

[2. (Sun2022Comprehensive) Xiangran Sun, Di Zheng, and Weichun Guo. Comprehensive analysis of a zinc finger protein gene–based signature with regard to prognosis and tumor immune microenvironment in osteosarcoma. Frontiers in Genetics, February 2022. URL: http://dx.doi.org/10.3389/fgene.2022.835014, doi:10.3389/fgene.2022.835014. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2022.835014)

[3. (Cuna2015Alterations) Alain Cuna, Brian Halloran, Ona Faye-Petersen, David Kelly, David K. Crossman, Xiangqin Cui, Kusum Pandit, Naftali Kaminski, Soumyaroop Bhattacharya, Ausaf Ahmad, Thomas J. Mariani, and Namasivayam Ambalavanan. Alterations in gene expression and dna methylation during murine and human lung alveolar septation. American Journal of Respiratory Cell and Molecular Biology, 53(1):60–73, July 2015. URL: http://dx.doi.org/10.1165/rcmb.2014-0160OC, doi:10.1165/rcmb.2014-0160oc. This article has 62 citations and is from a peer-reviewed journal.](https://doi.org/10.1165/rcmb.2014-0160OC)